Key Points:

• The Company’s AGM will be held on April 28, 2025, at 10:00 a.m.
• The meeting will discuss and vote on several key resolutions, including:
• Receipt and adoption of the Directors’ Statement and Audited Financial Statements for the financial year ended December 31, 2024.
• Declaration of a final tax-exempt (one-tier) dividend of 1.50 Singapore cents per ordinary share.
• Re-election of Directors, including Mr. Lim See Wah and Ms. Tan Seok Hoong @ Mrs. Audrey Liow.
• Approval of Directors’ fees of S\$257,000 for the financial year ended December 31, 2024.
• Re-appointment of RSM SG Assurance LLP as the Auditors of the Company.
• Authority to allot and issue new shares and convertible securities.
• Grant of awards and allotment of shares under the Hyphens Performance Share Plan and Hyphens Employee Share Option Scheme.
• Renewal of the share buy-back mandate.

Important Takeaways for Shareholders:

• The Company’s AGM will determine the entitlements to a final tax-exempt (one-tier) dividend of 1.50 Singapore cents per ordinary share for the financial year ended December 31, 2024.
• The proposed dividend, if approved, will be paid on May 23, 2025.
• Shareholders will need to ensure that their Securities Accounts with The Central Depository (Pte) Limited (“CDP”) are credited with ordinary shares in the capital of the Company as at 5:00 p.m. on May 8, 2025, to be entitled to the proposed final dividend.

Resolutions that May Affect Share Values:

• Authority to allot and issue new shares and convertible securities: This resolution may have a dilutive effect on existing shareholders if new shares are issued.
• Renewal of the share buy-back mandate: This resolution may impact the Company’s share price if the Directors exercise the authority to purchase or acquire issued ordinary shares.
• Grant of awards and allotment of shares under the Hyphens Performance Share Plan and Hyphens Employee Share Option Scheme: This resolution may impact the Company’s share price if a significant number of shares are issued under these schemes.

Proxy Form and Attendance:

• Shareholders may attend the AGM in person or appoint a proxy to vote on their behalf.
• The duly executed Proxy Form must be submitted to the Company by April 25, 2025, at 10:00 a.m.

Disclaimer: This article is for informational purposes only and should not be considered as investment advice. Shareholders should carefully read the notice of AGM and consult with their financial advisors before making any investment decisions.

View Hyphens Pharma Historical chart here